Practice Point CME - Cardiology Podcast

About Practice Point CME - Cardiology Podcast

Tune into our cardiology podcasts, an audio resource designed for learning about heart health. Throughout these podcasts, leading experts cover a wide range of topics in cardiology, including the latest research, clinical practices, and case-studies. Episodes may dive into specific conditions such as hypertension, heart failure, and cardiovascular disease prevention, as well as preventative strategies, diagnostic methods, and treatment options. With insights from our top cardiologists, this podcast series aims to keep health care professionals informed about advancements in cardiovascular medicine to overall improve patient care.

Publisher

Practice Point Communications

Category

education

Language

en

Explicit

No

First episode

9 Jan 2025

Latest episode

20 May 2026

Latest episodes

8 episodes in the feed.

1. 

   20 May 2026

   Episode 8 - HCM Podcast: Translating Cases into Care - Comprehensive Management - Long-Term Strategies and the Care Team - Part 3

   Hypertrophic Cardiomyopathy (HCM) is often missed or inconsistently treated despite progress in diagnostic tools and treatment options. Clinicians frequently encounter difficulties with early identification, distinguishing HCM from similar conditions, and implementing evolving approaches to risk stratification and therapy. In this three-part podcast series, Drs. Theodore Abraham and Martin Maron highlight practical approaches for better recognition, diagnosis, and management of HCM. Launch Date/Release: May 20, 2026 Expiration Date: April 30, 2026 FACULTY Theodore Abraham, MD Distinguished Professor of Medicine University of California, San Francisco Martin Maron, MD Director, Hypertrophic Cardiomyopathy Center Lahey Hospital & Medical Center This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link (https://www.practicepointcme.com/CMEHome/hcm-podcast-translating-cases-into-care) prior to listening to this podcast.

2. 

   20 May 2026

   Episode 7 - HCM Podcast: Translating Cases into Care - Treating HCM - Optimizing Therapy in Obstructive and Non-Obstructive Disease - Part 2

   Hypertrophic Cardiomyopathy (HCM) is often missed or inconsistently treated despite progress in diagnostic tools and treatment options. Clinicians frequently encounter difficulties with early identification, distinguishing HCM from similar conditions, and implementing evolving approaches to risk stratification and therapy. In this three-part podcast series, Drs. Theodore Abraham and Martin Maron highlight practical approaches for better recognition, diagnosis, and management of HCM. Launch Date/Release: May 20, 2026 Expiration Date: April 30, 2026 FACULTY Theodore Abraham, MD Distinguished Professor of Medicine University of California, San Francisco Martin Maron, MD Director, Hypertrophic Cardiomyopathy Center Lahey Hospital & Medical Center This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link (https://www.practicepointcme.com/CMEHome/hcm-podcast-translating-cases-into-care) prior to listening to this podcast.

3. 

   20 May 2026

   Episode 6 - HCM Podcast: Translating Cases into Care - Recognizing HCM - When to Suspect, What to Test - Part 1

   Hypertrophic Cardiomyopathy (HCM) is often missed or inconsistently treated despite progress in diagnostic tools and treatment options. Clinicians frequently encounter difficulties with early identification, distinguishing HCM from similar conditions, and implementing evolving approaches to risk stratification and therapy. In this three-part podcast series, Drs. Theodore Abraham and Martin Maron highlight practical approaches for better recognition, diagnosis, and management of HCM. Launch Date/Release: May 20, 2026 Expiration Date: April 30, 2026 FACULTY Theodore Abraham, MD Distinguished Professor of Medicine University of California, San Francisco Martin Maron, MD Director, Hypertrophic Cardiomyopathy Center Lahey Hospital & Medical Center This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link (https://www.practicepointcme.com/CMEHome/hcm-podcast-translating-cases-into-care) prior to listening to this podcast.

4. 

   2 Sept 2025

   Episode 5 - Clinical Clips in Hypertrophic Cardiomyopathy: Highlighting Key Data Presented at ESC Congress 2025

   During this educational podcast, Dr. Martin Maron highlights the latest advances in HCM presented at the ESC Congress 2025 in Madrid, Spain, August 29-September 1, 2025. Noteworthy presentations, posters, and abstracts are presented from the conference that are of high clinical significance to improve HCM. Launch Date: September 2, 2025 Release Date: September 2, 2025 Expiration Date: August 31, 2026 FACULTY Martin S. Maron, MD Director, Hypertrophic Cardiomyopathy Center Lahey Hospital & Medical Center Massachusetts, USA This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link (https://www.practicepointcme.com/CMEHome/clinical-clips-in-hypertrophic-cardiomyopathy-highlighting-key-data-presented-at-esc-congress-2025-1) prior to listening to this podcast.

5. 

   19 Jan 2025

   Episode 4 - ACC Conference Coverage: Clinical Clips in Heart Failure

   This is an accredited continuing education series of one (1) podcast as a downloadable audio file (MP3). This certified AMA/ABS/ANCC/ACPE podcast will spotlight latest advances in the treatment of HF featuring a leading expert reporting from the 2024 ACC Conference. Launch Date: April 11, 2024 Release Date: April 11, 2024 Expiration Date: March 31, 2025 FACULTY BIO Peter P. Toth, MD, PhD, FCCP, FESC, FAHA, FACC Director of Preventive Cardiology CGH Medical Center Professor of Clinical Family and Community Medicine University of Illinois School of Medicine Adjunct Professor of Medicine Division of Cardiology Johns Hopkins University School of Medicine This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode. https://www.practicepointcme.com/CMEHome/acc-conference-coverage-clinical-clips-in-heart-failure-1 (https://www.practicepointcme.com/CMEHome/acc-conference-coverage-clinical-clips-in-heart-failure-1)

6. 

   19 Jan 2025

   Episode 3 - Talking Cardiovascular Disease Prevention: Emerging Strategies to Address Management Challenges in Dyslipidemia - Part 3

   Dyslipidemia is a well-known risk factor for the development of cardiovascular disease, a leading cause of morbidity and mortality. Treatment of dyslipidemia represents one of the most crucial strategies to reduce risk of atherosclerotic cardiovascular (CV) disease (ASCVD). In this podcast series, Dr. Deepak Bhatt and Dr. R. Scott Wright discuss recent clinical trial evidence for CV risk reduction with cholesterol-lowering therapies, with a focus on CV outcomes trials with current and emerging therapies that target proprotein convertase subtilisin/kexin type 9 (PCSK9). Launch Date: February 16, 2024 Release Date: January 29, 2024 Expiration Date: January 31, 2025 FACULTY R. Scott Wright, MD, FACC, FESC, FAHA Professor of Medicine Consultant in Cardiology Mayo Clinic Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI Director Mount Sinai Fuster Heart Hospital Dr. Valentin Fuster Professor of Cardiovascular Medicine Icahn School of Medicine at Mount Sinai This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode. https://www.practicepointcme.com/CMEHome/talking-cardiovascular-disease-prevention-emerging-strategies-to-address-management-challenges-in-dyslipidemia-1 (https://www.practicepointcme.com/CMEHome/talking-cardiovascular-disease-prevention-emerging-strategies-to-address-management-challenges-in-dyslipidemia-1)

7. 

   19 Jan 2025

   Episode 2 - Talking Cardiovascular Disease Prevention: Emerging Strategies to Address Management Challenges in Dyslipidemia - Part 2

   Dyslipidemia is a well-known risk factor for the development of cardiovascular disease, a leading cause of morbidity and mortality. Treatment of dyslipidemia represents one of the most crucial strategies to reduce risk of atherosclerotic cardiovascular (CV) disease (ASCVD). In this podcast series, Dr. Deepak Bhatt and Dr. R. Scott Wright discuss recent clinical trial evidence for CV risk reduction with cholesterol-lowering therapies, with a focus on CV outcomes trials with current and emerging therapies that target proprotein convertase subtilisin/kexin type 9 (PCSK9). Launch Date: February 16, 2024 Release Date: January 29, 2024 Expiration Date: January 31, 2025 FACULTY R. Scott Wright, MD, FACC, FESC, FAHA Professor of Medicine Consultant in Cardiology Mayo Clinic Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI Director Mount Sinai Fuster Heart Hospital Dr. Valentin Fuster Professor of Cardiovascular Medicine Icahn School of Medicine at Mount Sinai This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode. https://www.practicepointcme.com/CMEHome/talking-cardiovascular-disease-prevention-emerging-strategies-to-address-management-challenges-in-dyslipidemia-1 (https://www.practicepointcme.com/CMEHome/talking-cardiovascular-disease-prevention-emerging-strategies-to-address-management-challenges-in-dyslipidemia-1)

8. 

   9 Jan 2025

   Episode 1 - Talking Cardiovascular Disease Prevention: Emerging Strategies to Address Management Challenges in Dyslipidemia - Part 1

   Dyslipidemia is a well-known risk factor for the development of cardiovascular disease, a leading cause of morbidity and mortality. Treatment of dyslipidemia represents one of the most crucial strategies to reduce risk of atherosclerotic cardiovascular (CV) disease (ASCVD). In this podcast series, Dr. Deepak Bhatt and Dr. R. Scott Wright discuss recent clinical trial evidence for CV risk reduction with cholesterol-lowering therapies, with a focus on CV outcomes trials with current and emerging therapies that target proprotein convertase subtilisin/kexin type 9 (PCSK9).Launch Date: February 16, 2024Release Date: January 29, 2024Expiration Date: January 31, 2025 FACULTY R. Scott Wright, MD, FACC, FESC, FAHA Professor of Medicine Consultant in Cardiology Mayo Clinic Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI Director Mount Sinai Fuster Heart Hospital Dr. Valentin Fuster Professor of Cardiovascular Medicine Icahn School of Medicine at Mount Sinai This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link (https://www.practicepointcme.com/CMEHome/talking-cardiovascular-disease-prevention-emerging-strategies-to-address-management-challenges-in-dyslipidemia-1) prior to listening to this episode.

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

5.0 / 5

1 ratings

Spotify

5.0 / 5

2 ratings

Podcast Authority Score: 2 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

4

Social presence

0

YouTube

0

Engagement

0

Contact Practice Point CME - Cardiology Podcast

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.